Scott L Burrows

Chief Financial Officer, Spyre Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$9.1M

Companies

Latest trade

Oct 1, 2026

Companies

Spyre Therapeutics, Inc.Chief Financial Officer −$9.1M

Trades

SYRE Sold 7,500 shares at $91.83 · planned $0.7M Oct 1

SYRE Sold 17,500 shares at $89.89 · planned $1.6M Sep 30

SYRE Sold 18,232 shares at $89.35 · planned $1.6M Sep 2

SYRE Sold 7,500 shares at $87.31 · planned $0.7M Sep 1

SYRE Sold 7,500 shares at $95.57 · planned $0.7M Aug 3

SYRE Sold 7,500 shares at $87.74 · planned $0.7M Jul 1

SYRE Sold 15,000 shares at $87.13 $1.3M Jun 25

SYRE Sold 7,500 shares at $71.06 · planned $0.5M Jun 1

SYRE Sold 12,500 shares at $71.37 · planned $0.9M May 1

SYRE Sold 7,500 shares at $49.34 · planned $0.4M Apr 1

SYRE Sold 2,500 shares at $40.65 · planned $0.1M Mar 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.